ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novel natural killer cell engager therapy shows promise in Phase I trials
April 15, 2021GTB-3550 TriKE™ monotherapy was found to restore natural killer cell function and immune surveillance in relapsed or refractory AML and MDS cancer patients. -
Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer
March 09, 2021Wugen Inc., a clinical-stage biotechnology company developing novel universal natural killer (NK) and T-cell therapies for the treatment of cancer, announced that it has entered into an exclusive license and collaboration agreement with Shanghai-based ... -
NK Ingredients' Singapore site receives EXCiPACT GMP certification
June 15, 2017EXCiPACT is delighted to announce that the NK Ingredients Singapore site has recently been awarded an EXCiPACT certificate from SGS, one of EXCIPACT’s internationally recognised certification bodies.
Pharma Sources Insight January 2025
